Details of the first study by one of Europe’s largest cancer centers assessing the clinical impact and feasibility of the ESMO Magnitude of Clinical Benefit Scale in a real-life context are now available to the public.
Details of the first study by one of Europe’s largest cancer centers assessing the clinical impact and feasibility of the ESMO Magnitude of Clinical Benefit Scale in a real-life context are now available to the public.